PNC FINANCIAL SERVICES GROUP, INC. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,637
-40.4%
1,679
-14.8%
0.00%
Q2 2023$58,164
+73.4%
1,971
+35.4%
0.00%
Q1 2023$33,546
-27.7%
1,456
-12.8%
0.00%
Q4 2022$46,415
+71.9%
1,669
+85.2%
0.00%
Q3 2022$27,000
+12.5%
901
+10.1%
0.00%
Q2 2022$24,000
-11.1%
818
-2.4%
0.00%
Q1 2022$27,000
-58.5%
838
-42.3%
0.00%
Q4 2021$65,000
+6.6%
1,452
+19.9%
0.00%
Q3 2021$61,000
-16.4%
1,211
+30.4%
0.00%
Q2 2021$73,000
+40.4%
929
+1.3%
0.00%
Q1 2021$52,000
-33.3%
917
-1.1%
0.00%
Q4 2020$78,000
+136.4%
927
+0.3%
0.00%
Q3 2020$33,000
+50.0%
9240.0%0.00%
Q2 2020$22,000
+37.5%
924
+0.8%
0.00%
Q1 2020$16,000
+77.8%
917
+83.4%
0.00%
Q4 2019$9,000
+12.5%
5000.0%0.00%
Q3 2019$8,000
-20.0%
5000.0%0.00%
Q2 2019$10,000
-16.7%
5000.0%0.00%
Q1 2019$12,000
+20.0%
5000.0%0.00%
Q4 2018$10,000
-16.7%
500
-6.7%
0.00%
Q3 2018$12,000
+50.0%
536
+7.2%
0.00%
Q2 2018$8,0005000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders